G1 Therapeutics (NASDAQ:GTHX) reported its Q4 earnings results on Wednesday, February 23, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
G1 Therapeutics beat estimated earnings by 8.74%, reporting an EPS of $-0.94 versus an estimate of $-1.03.
Revenue was up $10.75 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 0.06% increase in the share price the next day.
Here's a look at G1 Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1 | -0.97 | -1.07 | -0.87 |
| EPS Actual | -1 | -0.94 | -0.65 | -0.67 |
| Revenue Estimate | 5.18M | 2.59M | 770.00K | 4.06M |
| Revenue Actual | 4.86M | 6.60M | 14.22M | 16.55M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
